Sana M. Al‐Khatib

Learn More
A trial fibrillation (AF) is a global health problem. The condition brings an increased risk of stroke, systemic embolism, and heart failure (HF) and is associated with impaired quality of life, frequent hospitalizations, and mortality. 1 Observational studies have been the main source of information for many years and have defined the clinical(More)
  • 1